Breadcrumb

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

IDIGH Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Two awards for a Canadian postdoc at meeting that sets the gold standard of HIV science

RI-MUHC trainee Stéphane Isnard honoured for his research on gut permeability in HIV

Multiple honours for Dr. Évelyne Vinet

RI-MUHC researcher earns distinctions from the European League Against Rheumatism, Laurentian Conference of Rheumatology and McGill University

Five RI-MUHC members named CRC Chairs

Congratulations to five members of the Research Institute of the McGill University Health Centre (RI-MUHC)

Dr. Donald Sheppard appointed Chair of the Department of Microbiology and Immunology

Dr. Donald Sheppard has been appointed to the position of Chair of the Department of Microbiology and Immunology in the Faculty of Medicine, McGill University, as of July 1.

MI4 unveils first round of Seed Fund Grants

Interdisciplinary and multi-institutional projects aim to tackle infectious and immune threats to human health

The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

Recognizing great ideas at the McGill Clinical Innovation Competition

Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!

Guidelines for managing anaphylaxis in children need an update

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet

The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity

Widespread off-label use of epilepsy medications could put some patients at risk

Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain

Explore news and events at the RI-MUHC